These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8131669)

  • 21. Chronobiologic aspects of urinary gonadotropin peptide (UGP).
    Cornélissen G; Halberg F; Walker R; Zaslavskaya RM; Fine RL; Haus E
    In Vivo; 1995; 9(4):359-62. PubMed ID: 8555435
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical chronobiology and chronotherapeutics with applications to asthma.
    Smolensky MH; Reinberg AE; Martin RJ; Haus E
    Chronobiol Int; 1999 Sep; 16(5):539-63. PubMed ID: 10513882
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronobiology, drug delivery, and chronotherapeutics.
    Smolensky MH; Peppas NA
    Adv Drug Deliv Rev; 2007 Aug; 59(9-10):828-51. PubMed ID: 17884237
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The 'Sentinel Node' Concept: More Questions Raised than Answers Provided?
    Schlag PM
    Oncologist; 1998; 3(5):VI-VII. PubMed ID: 10388128
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Closing Remarks.
    Reed E
    Oncologist; 1996; 1(4):276-277. PubMed ID: 10388002
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Implications of circadian clocks for the rhythmic delivery of cancer therapeutics.
    Lévi F; Focan C; Karaboué A; de la Valette V; Focan-Henrard D; Baron B; Kreutz F; Giacchetti S
    Adv Drug Deliv Rev; 2007 Aug; 59(9-10):1015-35. PubMed ID: 17692427
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronopharmacology: a therapeutic frontier.
    Halberg F; Kabat HF; Klein P
    Am J Hosp Pharm; 1980 Jan; 37(1):101-6. PubMed ID: 7361768
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cancer Drug Development: New Targets for Cancer Treatment.
    Curt GA
    Oncologist; 1996; 1(3):II-III. PubMed ID: 10387987
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alternative strategies in drug development: clinical pharmacological aspects.
    Kuhlmann J
    Int J Clin Pharmacol Ther; 1999 Dec; 37(12):575-83. PubMed ID: 10599949
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronometaanalysis: circasemiseptan (3.5-day) pattern in mitotic activity of murine sarcoma after treatment with cyclophosphamide.
    Focan C; Cornélissen G; Halberg F
    In Vivo; 1995; 9(4):401-6. PubMed ID: 8555441
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A clinical development paradigm for cancer vaccines and related biologics.
    Hoos A; Parmiani G; Hege K; Sznol M; Loibner H; Eggermont A; Urba W; Blumenstein B; Sacks N; Keilholz U; Nichol G;
    J Immunother; 2007 Jan; 30(1):1-15. PubMed ID: 17198079
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The NCI All Ireland Cancer Conference.
    Johnston PG; Daly PA; Liu E
    Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Implementing a decision-theoretic design in clinical trials: why and how?
    Palmer CR; Shahumyan H
    Stat Med; 2007 Nov; 26(27):4939-57. PubMed ID: 17582801
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug research: from the idea to the product.
    Kuhlmann J
    Int J Clin Pharmacol Ther; 1997 Dec; 35(12):541-52. PubMed ID: 9455711
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical trial designs for predictive marker validation in cancer treatment trials.
    Sargent DJ; Conley BA; Allegra C; Collette L
    J Clin Oncol; 2005 Mar; 23(9):2020-7. PubMed ID: 15774793
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The analysis of physicians' work: announcing the end of attempts at in vitro fertilization].
    Santiago-Delefosse M; Cahen F; Coeffin-Driol C
    Encephale; 2003; 29(4 Pt 1):293-305. PubMed ID: 14615699
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circasemiseptan (about-half-weekly) and/or circaseptan (about-weekly) pattern in human mitotic activity?
    Blank M; Cornélissen G; Halberg F
    In Vivo; 1995; 9(4):391-4. PubMed ID: 8555439
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronopharmacology and its impact on antihypertensive treatment.
    Lemmer B
    Acta Physiol Pharmacol Bulg; 1999; 24(3):71-80. PubMed ID: 10736610
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.